A family of NAD⁺/NADH-dependent enzymes that catalyze the reversible interconversion between active Cortisol (cortisol) and inactive cortisone, creating tissue-specific glucocorticoid gradients independent of systemic HPA axis output. Two key isoforms exist: 11β-HSD1 (reductase) amplifies local Cortisol in metabolic tissues (liver, adipose, brain), while 11β-HSD2 (dehydrogenase) inactivates Cortisol in mineralocorticoid-sensitive tissues (kidney, colon, placenta), protecting these sites from glucocorticoid excess and preventing inappropriate Mineralocorticoid Receptor activation.
Think of 11β-HSD as a currency exchange operating at the border between two countries. The "active currency" is Cortisol—powerful, spendable, gets things done. The "inactive currency" is cortisone—inert, must be converted first.
11β-HSD2 is the border guard at sensitive checkpoints (kidneys, placenta, salivary glands). When Cortisol tries to cross, the guard confiscates it and hands back worthless cortisone. This protects the local economy from being flooded with stress dollars that would crash the system. During Pregnancy, the placental border guard is especially strict—maternal stress hormones trying to reach the fetus get neutralized 80-90%, creating a protective gradient.
11β-HSD1 works the opposite direction in metabolic hubs (liver, fat depots, hippocampus). It's like a local money printer that takes inactive cortisone from circulation and converts it back to spendable Cortisol. Even when the central bank (HPA axis) isn't printing much money, these local printers can flood the tissue with stress currency. In metabolic syndrome, liver and fat tissue run their printers overtime—systemic Cortisol might look normal in blood, but inside the tissue, it's a glucocorticoid hurricane driving insulin resistance and fat accumulation.
Enzyme structure: NAD⁺-dependent dehydrogenase, highly tissue-specific (kidney distal tubules, colon, placental syncytiotrophoblasts, salivary glands)
Reaction catalyzed:
Cortisol + NAD⁺ → Cortisone + NADH + H⁺
Functional mechanism:
- Active Cortisol (KD ~1-10 nM for Mineralocorticoid Receptor) enters cell
- 11β-HSD2 oxidizes the 11β-hydroxyl group to 11-keto, creating inert cortisone
- Cortisone has >100-fold lower affinity for Mineralocorticoid Receptor
- Aldosterone (which lacks the 11β-hydroxyl) bypasses this enzyme, selectively activating mineralocorticoid signaling
- Maintains sodium/potassium balance in kidney collecting duct despite circulating Cortisol being 100-1000× higher than Aldosterone
Placental protection cascade:
- Placental 11β-HSD2 activity peaks in third trimester
- Converts 80-95% of maternal Cortisol to cortisone before reaching fetal circulation
- Fetal Cortisol exposure ~10% of maternal levels
- Reduced enzyme activity (genetic variants, stress, liquorice consumption) → increased fetal glucocorticoid exposure → developmental programming of HPA dysregulation, insulin resistance, hypertension in offspring
- Exam critical: This is Programme 1 protection—the fetus is pre-programmed for the metabolic/stress environment it will encounter based on maternal signals
Inhibition:
- Glycyrrhizin (liquorice) is a potent competitive inhibitor (IC50 ~5 μM)
- Inhibition → apparent mineralocorticoid excess syndrome: hypertension, hypokalemia, metabolic alkalosis despite low Aldosterone
Enzyme structure: NADPH-dependent reductase (bidirectional in vitro, predominantly reductase in vivo), expressed in liver, adipose (especially visceral), brain (hippocampus, amygdala), skeletal muscle, vascular endothelium
Reaction catalyzed:
Cortisone + NADPH + H⁺ → Cortisol + NADP⁺
Intracellular amplification mechanism:
- Cortisone-cortisol shuttle operates across cell membrane
- Cortisol-binding globulin (CBG) carries cortisol in blood; cortisone circulates free
- Free cortisone enters cell → 11β-HSD1 regenerates Cortisol
- Intracellular Cortisol concentration exceeds plasma free Cortisol by 2-4 fold in liver, 3-10 fold in visceral adipose
- Local Cortisol activates Glucocorticoid Receptor → metabolic reprogramming independent of systemic HPA tone
Tissue-specific effects:
Liver:
Visceral adipose:
- Cortisol → adipocyte differentiation (preadipocyte → mature adipocyte)
- Upregulates Lipoprotein lipase → triglyceride storage
- Downregulates hormone-sensitive lipase → reduced lipolysis
- Creates positive feedback: adiposity → inflammatory cytokines (IL-6, TNF-α) → further 11β-HSD1 expression
- Visceral fat accumulation pattern despite normal/low systemic Cortisol
Hippocampus:
graph TD
A[Circulating Cortisone] -->|Cell entry| B[Intracellular Space]
B -->|"11β-HSD1 + NADPH"| C[Active Cortisol]
C -->|GR activation| D[Glucocorticoid Receptor]
D --> E[Metabolic Effects]
D --> F[Inflammatory Modulation]
D --> G[Cognitive Effects]
E --> E1["Liver: ↑ Gluconeogenesis"]
E --> E2["Adipose: ↑ Lipogenesis"]
E --> E3["Muscle: ↓ Glucose uptake"]
F --> F1["↓ NFκB in acute stress"]
F --> F2["↑ IL-6, TNF-α in chronic"]
G --> G1["Hippocampus: ↓ BDNF"]
G --> G2["↓ Neurogenesis"]
H[Circulating Cortisol] -->|Entry into kidney/placenta| I["11β-HSD2 Tissues"]
I -->|"11β-HSD2 + NAD+"| J[Inactive Cortisone]
J -->|Exits cell| K[Protection from GR activation]
K --> L[MR remains selective for aldosterone]
Developmental programming (Module 2 core concept):
Placental 11β-HSD2 deficiency represents the clearest example of Programme 1 metabolic imprinting. Maternal stress during pregnancy suppresses placental enzyme activity via inflammatory cytokines (IL-1β, TNF-α), increasing fetal glucocorticoid exposure. This programs:
- Permanent HPA axis hyperresponsiveness (lower glucocorticoid negative feedback sensitivity)
- Insulin resistance and Type 2 Diabetes risk (30-50% increased risk with low birth weight)
- Hypertension in adulthood (fetal kidneys exposed to excess glucocorticoids develop fewer nephrons)
- Anxiety/depression vulnerability (altered amygdala-prefrontal connectivity)
Clinical screening: Birth weight <2500g + maternal stress history → monitor offspring for metabolic syndrome markers by age 30.
Metabolic syndrome and apparent euadrenalism:
Patients with metabolic syndrome often have normal or even low morning serum Cortisol, yet exhibit tissue-level hypercortisolism due to 11β-HSD1 overactivity. This explains:
- Central obesity despite "normal" Cortisol awakening response
- Hepatic insulin resistance (excess hepatic Cortisol → constitutive gluconeogenesis)
- Why urinary cortisol metabolites (tetrahydrocortisol + allo-tetrahydrocortisol) are elevated while plasma Cortisol is not
Intervention implications:
- Exercise downregulates adipose 11β-HSD1 expression (30-40% reduction with regular vigorous activity)
- Omega-3 fatty acids (EPA/DHA >2g/day) reduce hepatic enzyme expression
- Liquorice (glycyrrhizin) inhibits both isoforms—avoid in pregnancy (removes fetal protection) and hypertension (mineralocorticoid excess)
- Selective 11β-HSD1 inhibitors in development for metabolic syndrome (reduce tissue glucocorticoid tone without affecting circulating levels)
Evolutionary medicine perspective:
11β-HSD2 in the placenta represents an evolved buffer against maternal environmental stress signals. In ancestral environments, maternal stress (famine, predation) predicted offspring environment—fetal programming was adaptive. Modern chronic psychological stress hijacks this system, creating maladaptive programming for obesogenic environments.
PTSD and trauma:
Altered 11β-HSD1 activity in hippocampus and prefrontal cortex contributes to PTSD symptomatology. Elevated enzyme expression amplifies local glucocorticoid signaling even when systemic Cortisol is low (common in chronic PTSD). This impairs fear extinction learning and contextual memory processing.
Diagnostic considerations:
- Salivary cortisol measures cortisone after 11β-HSD2 conversion in salivary glands
- Salivary cortisone/cortisol ratio reflects enzyme activity
- Elevated ratio (>1.0) suggests 11β-HSD2 hyperactivity; reduced ratio (<0.5) suggests deficiency or inhibition
- Urinary free cortisol underestimates tissue exposure if 11β-HSD1 is elevated (enzyme regenerates cortisol locally after renal filtration)
- 11β-HSD2 creates an 80-95% cortisol gradient across the placenta during pregnancy, protecting fetal brain development from maternal stress hormones
- Liquorice consumption >100g/day during pregnancy reduces enzyme activity and increases risk of offspring ADHD, anxiety disorders (10-year follow-up studies)
- Visceral adipose tissue 11β-HSD1 expression is 3-4× higher than subcutaneous fat, explaining the metabolic toxicity of central obesity
- Enzyme activity declines with age in hippocampus, increasing local glucocorticoid tone and contributing to age-related cognitive decline
- Genetic variants in HSD11B2 (gene encoding 11β-HSD2) associated with hypertension, low birth weight, and salt sensitivity
- 11β-HSD1 inhibitors reduce liver fat by 30% and improve insulin sensitivity in diabetic patients (Phase 2 trials)
- Chronic stress upregulates 11β-HSD1 in adipose via IL-6 and TNF-α signaling, creating a vicious cycle of inflammation → cortisol amplification → more inflammation
- Carbenoxolone (11β-HSD inhibitor) used clinically for gastric ulcers can cause hypertension and edema via mineralocorticoid excess
- Morning vs evening cortisol ratio does not reflect tissue-level exposure—need urinary metabolites or tissue-specific measures
- Fetal cortisol exposure correlates inversely with placental 11β-HSD2 activity (r = -0.7 in human studies)
- Selective 11β-HSD1 knockout mice are protected from diet-induced obesity, glucose intolerance, and atherosclerosis despite normal HPA axis function
- Cortisol — substrate for inactivation (11β-HSD2) or regeneration (11β-HSD1)
- HPA axis — tissue enzyme activity modulates local glucocorticoid exposure independent of central axis output
- Mineralocorticoid Receptor — 11β-HSD2 protects this receptor from cortisol binding, maintaining aldosterone selectivity
- Aldosterone — bypasses 11β-HSD2 metabolism due to lack of 11β-hydroxyl group
- Pregnancy — placental enzyme protects fetus from maternal stress hormone exposure
- developmental programming — reduced enzyme activity during gestation programs offspring metabolic and HPA dysfunction
- Intrauterine programming — mechanism linking maternal stress to offspring disease risk
- metabolic syndrome — 11β-HSD1 overactivity in liver and adipose drives insulin resistance and central obesity
- visceral adiposity — preferential enzyme expression amplifies local cortisol, promoting fat accumulation
- insulin resistance — hepatic cortisol regeneration drives constitutive gluconeogenesis
- Type 2 Diabetes — elevated hepatic 11β-HSD1 worsens glycemic control independently of systemic cortisol
- Gluconeogenesis — liver 11β-HSD1 amplifies cortisol-driven glucose production
- inflammation — IL-6 and TNF-α upregulate adipose 11β-HSD1, creating cortisol-inflammation positive feedback
- IL-6 — increases 11β-HSD1 expression in adipocytes
- TNF-α — upregulates enzyme in adipose and liver during chronic inflammation
- PTSD — altered hippocampal 11β-HSD1 contributes to cognitive symptoms despite low systemic cortisol
- cognitive decline — age-related enzyme upregulation in hippocampus impairs neuroplasticity
- Adult Hippocampal Neurogenesis — suppressed by local cortisol amplification via 11β-HSD1
- BDNF — downregulated by glucocorticoid excess in hippocampus
- Glucocorticoid Receptor — activated by locally regenerated cortisol
- hypertension — 11β-HSD2 deficiency allows cortisol to activate mineralocorticoid receptors in kidney
- acute stress — 11β-HSD2 provides rapid tissue protection during stress spikes
- chronic stress — upregulates 11β-HSD1 in metabolic tissues, amplifying glucocorticoid effects
- Exercise — downregulates adipose 11β-HSD1 expression, reducing tissue cortisol tone
- Omega-3 fatty acids — EPA/DHA reduce hepatic enzyme expression
- Evolutionary medicine — placental enzyme represents evolved maternal-fetal conflict resolution mechanism
- Liver — high 11β-HSD1 expression amplifies gluconeogenic drive
- adipose tissue — visceral depots show highest enzyme activity
- Hippocampus — local cortisol regeneration affects memory consolidation and emotional regulation
- Low-Grade Inflammation — chronically elevated cytokines drive tissue-specific enzyme dysregulation
- Cortisol resistance — may develop at receptor level while tissue regeneration remains intact, maintaining local effects